Navigation Links
NuVasive Announces Webcast and Conference Call of Fourth Quarter and Full Year 2007 Results
Date:1/25/2008

SAN DIEGO, Jan. 25 /PRNewswire-FirstCall/ -- NuVasive, Inc. (Nasdaq: NUVA), a medical device company focused on developing products for minimally disruptive surgical treatments for the spine, announced today details relating to its fourth quarter and full year 2007 earnings announcement, which will take place on Tuesday, February 19, 2008, after the close of the market.

NuVasive will hold a conference call on Tuesday, February 19, 2008 at 5:30 p.m. ET / 2:30 p.m. PT to discuss the results. The dial-in numbers are 1-877-407-4018 for domestic callers and 1-201-689-8471 for international. A live Webcast of the conference call will be available online from the investor relations page of the Company's corporate Website at http://www.nuvasive.com.

After the live Webcast, the call will remain available on NuVasive's Website, http://www.nuvasive.com, through March 19, 2008. In addition, a telephonic replay of the call will be available until March 11, 2008. The replay dial-in numbers are 1-877-660-6853 for domestic callers and 1-201-612-7415 for international callers. Please use account number 3055 and conference ID number 269394.

About NuVasive

NuVasive is a medical device company focused on the design, development and marketing of products for the surgical treatment of spine disorders. The Company's product portfolio is focused on applications in the over $4.2 billion U.S. spine fusion market. The Company's current principal product offering includes a minimally disruptive surgical platform called Maximum Access Surgery, or MAS(TM), as well as a growing offering of cervical and motion preservation products.

The MAS platform offers advantages for both patients and surgeons such as reduced surgery and hospitalization time and faster recovery. MAS combines three categories of current product offerings: NeuroVision(R) a proprietary
'/>"/>

SOURCE NuVasive, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. NuVasive to Host Investor Reception on September 11, 2007
2. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
3. US Oncology Announces Realignment of Executive Team
4. Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Second Generation Niacin Receptor Agonist Under Its Collaboration With Merck & Co., Inc.
5. Exelixis Announces January 31 Webcast of Presentation at the 2008 Wachovia Healthcare Conference
6. Cardica Announces Fiscal 2008 Second Quarter Financial Results and Business Progress
7. Neurocrine Biosciences Announces Conference Call and Webcast to Present Fourth Quarter and Year End 2007 Financial Results
8. Gerson Lehrman Group Announces Partnership With BIO to Provide Scientific Expertise for the BIO CEO & Investor Conference
9. Accuray Announces New Treatment Planning Service Offering
10. QED International Associates Announces Changes to the HealthShares(TM) Composite, HealthShares(TM) Cancer and HealthShares(TM) Neuroscience Indexes
11. Sharps Compliance Corp. Announces Purchase of Medical Waste Disposal Facility and Addition of Autoclave Technology

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...ERG, Austria, November 9 For more ...been working on the development of a,Brain-Compute...channel,between the brain and a computer. Such a s...municate or to control devices in their environmen...ome patients have been supervised by,the researche...
(Date:11/9/2009)... Four of the top 10 pharmaceutical giants u...ons to Health Canada. Datafarm’s announcemen...dian DIA Annual Meeting where Health Canada stated...y submit Hybrid eCTD regulatory submissions for Ne... permission request. , Ma...
(Date:11/8/2009)...VIEW, Calif. Nov. 5, 2009 Complete Genomics, a t...oday announced publication of a report in the jour...ncing platform, including analysis of sequence dat...es cost for these three genomes sequenced on the p...om $8,005 for 87x coverage to $1,726 for 45x cover...
(Date:11/6/2009)...rio, Nov. 6 Helix BioPha...oday announced that John Docherty, president and c...urhan Ford,s 6th annual Investor Summit on Novembe...York City. Mr. Docherty will provide an overview ...ams L-DOS47 and Topical Interferon Alpha-2b. The ...
Breaking Biology Technology:intendiX - Communication by Thoughts: First Patient-Ready System on the Market 2Datafarm Responds to Health Canada's Announcement of Hybrid eCTD Submission Procedural Simplification 2Complete Genomics publishes in Science on low-cost sequencing of 3 human genomes 2Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 2Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 3
...n Scheduled for Wednesday, May 7th at 9:30am EDT, ...asdaq: KERX ) today announced that Michael S. Wei...icer, is scheduled to present at the,Deutsche Bank...sachusetts., Mr. Weiss, presentation, which will ...ll be webcast live and will be accessible from the...
...y 5 /PRNewswire-FirstCall/ - Lorus Therapeutics In...tical company dedicated in,the research, developme...s,and technologies for the management of cancer, a... management team with the appointment of Dr. Saeid...and Dr. Yoon Lee to,Vice-President of Research. Bo...
...RANCISCO, Calif., May 5 VaxGen,Inc. (OTC Bulletin...ounced,today it has completed the sale of all asse...e antigen (rPA) anthrax vaccine product candidate ...nc. Under the terms of the,transaction, Emergent B...of,the definitive agreement and may be obligated t...
Other Biology Technology:Keryx Biopharmaceuticals to Present at the Deutsche Bank 33rd Annual Health Care Conference 2Lorus Therapeutics Strengthens Its Senior Management Team Through Internal Promotions 2Lorus Therapeutics Strengthens Its Senior Management Team Through Internal Promotions 3Lorus Therapeutics Strengthens Its Senior Management Team Through Internal Promotions 4VaxGen Sells Anthrax Vaccine Program and Related Assets and Technology to Emergent BioSolutions, Inc. 2
(Date:11/6/2009)...s generally live in harmony with their arboreal ho...out of space in their trees of choice, the ants ca...search, published in the November issue of the Am...ants bore into live trees, and it reopens a centur...d plants. , Ants and certain species of plants a...
(Date:11/5/2009)...esearchers at Yale University have developed synth...une response to HIV and HIV-infected cells, as wel...lished online in the Journal of the American Chem...roaches for these diseases. , The molecules ca...(ARM-H) and "antibody-recruiting molecule targetin...
(Date:11/4/2009)...ridors in the cities of Long Beach and Riverside a...ventable childhood asthma, and the true impact of ...s likely been underestimated, according to researc...). , The study, which appears in an online edit...timated that nine percent of all childhood asthma ...
Breaking Biology News(10 mins):Ants are friendly to some trees, but not others 2New synthetic molecules trigger immune response to HIV and prostate cancer 2USC study finds big air pollution impacts on local communities 2Sinovac Schedules 2008 Annual General Meeting 48447 1Sinovac Schedules 2008 Annual General Meeting 48447 2The University of Miami Miller School of Medicine the City of Miami Microsoft and Resolute Solutions Seek to Improve Care of Diabetic Populations Us 48442 1The University of Miami Miller School of Medicine the City of Miami Microsoft and Resolute Solutions Seek to Improve Care of Diabetic Populations Us 48442 2The University of Miami Miller School of Medicine the City of Miami Microsoft and Resolute Solutions Seek to Improve Care of Diabetic Populations Us 48442 3American Academy of Pediatric Dentistry Releases New Perinatal and Infant Oral Health Guidelines 48437 1American Academy of Pediatric Dentistry Releases New Perinatal and Infant Oral Health Guidelines 48437 2American Academy of Pediatric Dentistry Releases New Perinatal and Infant Oral Health Guidelines 48437 3American Academy of Pediatric Dentistry Releases New Perinatal and Infant Oral Health Guidelines 48437 4
...ly of their own, members of some bird species will...r young. Now, researchers report evidence that in ...ost common among species that live in savannas, wh...possible to predict. The findings appear online Au...ion of Cell Press. , When the unpredictability of...
...ng hormone in African Americans known to potential...D., the senior author of a study in the September ...ciate professor of kinesiology at Temple Universit...aldosterone, influences the kidneys regulation of ...to the development of hypertension because it caus...
... new disease problems, a far more cost effective a...ate in the places where they often commingle: in w... to wildlife health experts from the Wildlife Cons... and Agriculture Organization (FAO) in a recent is...s. , This is an ounce of prevention that we reall...
Other Biology News:Uncertainty drives the evolution of 'cooperative breeding' in birds 2Understanding hypertension in African Americans proves elusive 2Emerging (disease) markets 2
Anti-Ezrin / Radixin / Moesin Antibody, Unconjugated from CHEMICON
Rat Anti-Mouse ABCA1 Monoclonal Antibody, Unconjugated, Clone 5A1-1422.11 from ABR-Affinity BioReagents
Goat Anti-Human SART3 Polyclonal Antibody, Unconjugated from Abcam
Mouse Anti-Hamartin Monoclonal Antibody, Unconjugated, Clone 1B2 from Cell Signaling Technology
Biology Products: